Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.
about
Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectiveInterethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individualsAssociation of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean SubjectsTherapeutic drug monitoring of voriconazole in Japanese patients: analysis based on clinical practice data.Implications of cytochrome P450 2C9 polymorphism on warfarin metabolism and dosing.Implementing genotype-guided antithrombotic therapy.The importance of drug interactions in epilepsy therapy.Revisiting the significance of warfarin protein-binding displacement interactions.Clinical implications of drug interactions with coxibs.The future prospects of pharmacogenetics in oral anticoagulation therapy.Pharmacogenetics of asthma.Personalised prescribing for asthma--is pharmacogenetics the answer?A review and assessment of potential sources of ethnic differences in drug responsiveness.Analysis of CYP2C9*2, CYP2C9*3 and VKORC1 -1639 G>A polymorphisms in a population from South-Eastern Europe.Allele and genotype frequencies of CYP2C9 in a Korean population.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy.Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.Frequency of cytochrome P450 2C9 mutant alleles in a Korean populationVitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirementGenetic polymorphisms and phenotypic analysis of drug-metabolizing enzyme CYP2C19 in a Li Chinese population.Pharmacogenomic effect of cytochrome P450 2C9 polymorphisms in different populations.Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese populationGenotype‑phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapyReaction phenotyping: current industry efforts to identify enzymes responsible for metabolizing drug candidates.Cytochrome P450 2C9-CYP2C9.Specific safety and tolerability considerations in the use of anticonvulsant medications in children.Randomised clinical trial: esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients.Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes.Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics.Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients.Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.Co-administration of proton pump inhibitors ameliorates nephrotoxicity in patients receiving chemotherapy with cisplatin and fluorouracil: a retrospective cohort study.Approach to the prediction of the contribution of major cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage.The role of genetics and ethnicity in epilepsy management.A High-Throughput (HTS) Assay for Enzyme Reaction Phenotyping in Human Recombinant P450 Enzymes Using LC-MS/MS.Genetic Polymorphisms of Cytochrome P450 2C19 in Functional Dyspeptic Patients Treated with Cimetidine.Voriconazole potentiates warfarin-induced prothrombin time prolongationCYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population.
P2860
Q27009221-8AAC080E-BBF8-42A4-9129-42C218C74041Q28237144-6BD936E4-90F4-4639-8867-232E2B22BFDDQ29308187-599314B8-B7D3-41E3-9073-1623711D114EQ30981299-3D12BB11-6011-4CAB-B7C0-B2B95F61A0C7Q32049910-046115CE-EC75-48FC-8DF5-87A43D0D7A87Q33990428-27AA920D-DEBA-449C-B2F2-E09203E34BF7Q34123652-D7CBE541-238D-46F8-8100-7C0DC89B3534Q34153426-B72BF240-7B2B-4A64-AABA-889411CA692FQ34401549-7F885048-C7D7-4BB3-9A84-900B3F54A207Q34530230-659D850D-1D38-4A70-931E-548211A58BA5Q34534425-D32EE684-60A5-4456-8E95-74F5017B409DQ35118280-7C4420AD-FB03-41F6-9984-E0421BED4E10Q35217493-756A8397-C2C8-479C-BF7D-AC0D4B3597DDQ35370240-1CF639D4-77E4-478A-9E62-5CADF4E49613Q35826938-AAD98311-9AEF-4D7A-BD6D-FE837057BE8BQ35876954-B07B32F4-CE98-44E4-A5D4-A03C3E371670Q36053279-C5520D6E-9800-476B-817D-9B973DA89397Q36054252-B696B096-11AF-426C-AA52-C48A0F713EF7Q36055401-B29296BA-ACEA-47F5-AC87-85873A42190EQ36062295-B041D835-383C-4924-9D11-BE7E009020A4Q36375369-8AD0D1AC-7F75-49C3-B777-433521CD8E29Q36481564-A1F5E7F3-D4EC-4D36-B9BA-42C18B09D5E1Q36535932-4DF8D5AE-3878-4DDF-86C0-BD0A938EAF1EQ36624080-1FE022BE-9149-4B79-9D05-5CCA27E57B5DQ37150887-BE9AC6CC-8911-4878-AD87-329E74AE8736Q37691210-3367DFA8-A452-44F8-8C94-5845291A6575Q38026034-94B26225-888C-46FE-88FE-B138B8747F38Q38471578-FDD88A11-FA40-4A00-A98A-3A96928A8D2DQ38616806-A4F9A3E8-28EA-4D92-B68E-D7935E93A761Q38643436-0E7708F5-083F-44C3-AE95-A456BF94EF14Q39232150-13669B82-30DB-4295-9455-81F44AB5C837Q39479653-9D2D6683-A24A-451B-B695-055100E0AD00Q40145641-0FB129E0-5B82-49D3-82BF-09D1C07BF5CCQ40264602-4B28FF81-8546-49AD-8730-3557523727EBQ40300462-B0F5AA00-18FC-47A1-8D46-555C9C35C3AEQ40379431-DC02D762-C4FF-4BFA-AABC-33F17CD65276Q40568343-1EC0D49D-D3CB-49E8-85C7-D5AD71928B52Q41624790-9B1A18F1-41A7-4614-A408-033DBCE609D4Q42029509-B5F4C207-257B-48EE-B5CB-D8070CD0D4F1Q42315488-09B0F978-8726-445C-ACC2-FCF07ACA460A
P2860
Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.
@en
Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.
@nl
type
label
Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.
@en
Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.
@nl
prefLabel
Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.
@en
Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.
@nl
P2093
P1476
Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population.
@en
P2093
P304
P356
10.1097/00007691-199806000-00001
P577
1998-06-01T00:00:00Z